Stroke Trial, Recruiting NCT06496529 Sponsor: University of Chile Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06496529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a stroke (either caused by a blocked blood vessel or by bleeding in the brain) within the past 12 weeks.
  • People whose affected arm and hand have limited voluntary movement, based on specific movement and strength tests showing reduced ability to lift the shoulder and extend the fingers (confirm with trial site for exact score requirements).

Who may not be able to join:

  • People with significant memory or thinking difficulties that would prevent them from giving consent, following instructions, or understanding the procedures involved (based on a standard cognitive test score below 18).
  • People who are unable to sit and participate in activities for more than 90 minutes, or who experience severe pain during activity, or who have very limited arm reach.
  • People with serious vision problems that would prevent them from completing the tasks involved in the trial.
  • People who had a previous stroke that left lasting problems affecting the arm being studied.
  • People who have movement or sensation problems on both sides of the body.
  • People whose brain scan shows damage to the cerebellum (the part of the brain that helps with coordination) or who show clear signs of cerebellar damage based on a standard assessment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pablo Burgos, PhD, University of Chile

Phone: 19713314101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Chile
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Change in UE-FMA at the end of the training; Change in UE-FMA at 6 months post stroke

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov